ghg Expands Barriers of Innovation with Inaugural Health Outcomes Code‑A‑Thon
New York, N.Y., October 6, 2014 – From September 20th to September 21st, ghg/NY, together with WG Consulting, hosted its first Health Outcomes Code‑A‑Thon as part of the Health Spoken Here series. The contest supported the formation of new ideas and prototypes that improve health outcome measures as they relate to the ACA and the larger U.S. healthcare system. Nine teams came together to present their ideas, all ranging from mental health awareness to the optimization of ACO and IDN networks. The expert panel of judges consisted of Managing Partners Lynn O’Connor Vos, Erin Byrne, John Dietz, and Ben Ingersoll. Guest judges in attendance were Ritesh Patel, Chief Digital Officer, Ogilvy Commonhealth Worldwide; Adam Griff, Healthcare Innovator and Entrepreneur, Health 2.0 NYC/MedStartr; and Thomas Tsang, Executive Director, Business Development and Strategy, Merck. After careful deliberation, the judges determined the top three winners:
Team Bright Day (First Place): Bright Day focused on a depression app that utilized Facebook to put a personalized aspect on depression and how it may affect the target audience’s immediate world of friends and family. The app allows users to identify friends or family that may be exhibiting signs of depression and connect with them through messaging. The app, using Facebook interests, can then suggest activities to do using outside APIs from Groupon, Yelp, Ticketmaster, etc.
Team Treatease (Second Place): Treatease presented an app focused on providing counseling for long term, post-care at an addiction treatment center to help reduce the need for readmissions. The app links counselors and patients for continuous care throughout the patient’s life.
Team Knife to 5K (Third Place): Knife to 5K presented an app focused on reducing hospital readmissions post-hip arthroplasty and reducing the cost of physical therapy in the longer term recovery of patients by expediting treatment. The app provides “virtual physical therapy” and also helps to track patients’ recovery progress back to healthcare professionals. The end goal is getting a person back to running 5ks after surgery.
For additional pictures and highlights from the event, visit our social media pages:
ghg’s EVP, Director of User Experience John Canevari to Judge 2014 Global Awards
John Canevari, ghg’s EVP and Director of User Experience, has been announced as a judge on the Executive Jury—a panel of top creative leaders from medical, pharmaceutical, and healthcare communication companies—for the 2014 Global Awards. Canevari and the Executive Jury will be responsible for judging the shortlist of winners and selecting the award winning campaigns honoring this year’s World’s Best Healthcare and Wellness Advertising.
Now in its 20th year, the Global Awards is one of the world’s largest and most recognized healthcare communications awards, showcasing creativity and innovation in 150 category entries, spanning regional, national, and continental boundaries. The 2014 awards ceremony will take place in November in New York City and Sydney, Australia. For more information, please visit http://www.theglobalawards.com.
Ben Ingersoll Appointed Chief Creative Officer of Grey Healthcare Group
New York, N.Y., August 11, 2014 – ghg (grey healthcare group) announced the appointment of Ben Ingersoll as Managing Partner and Chief Creative Officer. In this role, Ben joins fellow Managing Partners, Chief Engagement Officer Erin Byrne, and Brand Strategy Director John Dietz, in leading the New York agency.
“Ben brings with him extensive experience spanning nearly every therapeutic area, including diabetes and rare diseases,” notes Lynn O’Conner Vos, Chief Executive Officer of ghg. “We are pleased to add Ben to our team to drive creative excellence across ghg worldwide.”
Ben brings passion for creative ideas, great design and talent development to ghg. In his role, he will be responsible for all US creative operations, including copy, art, editorial and studio. He also will oversee collaboration among the agency’s global creative directors in London and Sydney to unify ghg’s creative point of view.
“ghg is a leader in the field, a company known for pushing the boundaries of communications and tech—I am absolutely thrilled to be joining the team,” notes Ben. “My goal is simple: to make ghg the hottest creative shop in healthcare, the go-to destination for clients and a magnet for the best creative talent.”
Prior to joining ghg, Ben served as Partner and Creative Director for Cline Davis & Mann New York where he was responsible for several global healthcare brands across multiple therapeutic areas.
Grey Healthcare Group Launches Health Spoken Here™ Series to Address Key Issues Affecting Health in the U.S.
New York, N.Y., May 30, 2014 – This week, ghg (Grey Healthcare Group) officially launched the Health Spoken Here™ series, a thought leadership series geared to discussing key issues impacting health in the U.S. ghg and market access consultancy WG Consulting partnered to host a much anticipated panel discussion - Realities of the Affordable Care Act: Can Value Be Legislated?
The panel, moderated by J.D. Kleinke, Health Care Business Strategist, brought together key influencers across the healthcare spectrum: Lynn O’Connor Vos, CEO, ghg; Lindsay Farrell, President and CEO, Open Door Family Medical Centers; Laurel Pickering, President and CEO, Northeast Business Group on Health; Bill Meury, Executive Vice President, Sales and Marketing, Forest Laboratories; and Dr. Nancy McGee, Managing Director, Manatt Health Solutions.
Among the many goals of the Affordable Care Act (ACA) is to rein in the ever-rising cost of healthcare in the United States, making all providers of care more accountable for the cost, quality and value of what they deliver. While the panel presented different viewpoints based on their line of expertise, everyone agreed: the changes from the ACA are making a difference. And because there is greater access to information that we did not have before, greater alignment exists among stakeholders.
“The major difference [between now and 1999] is technology, digital and the mass consumerization of health,” said Lynn O’Connor Vos, CEO of ghg. “You have consumers who are online, reaching Dr. Google, smarter than they were in ’99… you’re going to get a more educated consumer, which has to make a difference in healthcare, and it will make a difference for pharma as well.”
The Health Spoken Here series continues as ghg will host the Health Outcomes Code‑A‑Thon on June 21st and 22nd at the Ogilvy Chocolate Factory. The contest will bring together a community of developers, designers, entrepreneurs, healthcare professionals, and community members to formulate new ideas and prototypes that improve health outcome measures as they relate to the ACA and the larger U.S. healthcare system. For more information on this contest, please visit http://ghghealthoutcomescodeathon.challengepost.com/.
Claire Gillis, CEO, WG Consulting, Featured in March Issue of MM&M
The March 2014 issue of MM&M features an article by WG Consulting CEO Claire Gillis. WG Consulting, ghg's global healthcare market access consultancy, is a leader in aligning clinical, health economics and stakeholder analysis across all states of drug development. Their work in the healthcare realm allows them to identify current issues in the marketplace and provide real-world issues.
In this issue of MM&M, Claire utilizes her expertise in delivering evidence-based solutions to discuss "putting moves" on Big Data and what the healthcare sector can learn from consumer giants such as Amazon. Read more from her opinion piece at http://bit.ly/1dgYcu5.
WG Consulting Presents at 2014 New York Social Media Week
On February 19th, Caitlin McQuilling, Health Economist for WG Consulting, presented on behalf of "Team WG" during the Health Innovation Track for New York Social Media Week.
Now in its sixth year, Social Media Week has become a leading platform and worldwide event with local presence and global reach across Europe, North America, South America, Africa and Asia.
Team WG – consisting of Justin DiSanto, Yan Wang, and Caitlin McQuilling - was able to present at this year’s New York Social Media Week after winning Third Place in the Merck Social Health Hack. The "hackathon" provided the team with a chance to flesh out concepts and create innovative solutions that improve health literacy, manage chronic and acute illnesses, and improve overall wellbeing of the community. Team WG focused their efforts on finding a solution for Hepatitis C by designing an app, tentatively titled HepFree, to engage patients throughout their treatment and provide data to the physician and health system on adherence, side effects, and quality of life.
During New York Social Media Week, the team had the chance to present their work from the hackathon and network with major players in the health atmosphere, including Aetna, Merck, American Express, in addition to several prominent physicians and payers.
As a whole, the event provided the group with an opportunity to see first-hand how technology and social communication is becoming a growing opportunity in healthcare. Justin DiSanto stated, "It was a good experience to take part in the social aspects of healthcare. It was also great to shift from an onlooker to a participant at an event such as this."
This was the first year Social Media Week included a health track, signifying the growing importance of healthcare in the social realm.
For more information about Social Media Week, please visit http://socialmediaweek.org/.
Grey Healthcare Group & OptimizeRx Announce Partnership to Expand Offerings through EHRs
New York, N.Y., January 7, 2014—ghg (grey healthcare group) and OptimizeRx Corporation (OTCQB: OPRX) today announced an innovative partnership that will enable pharmaceutical/biotech companies and payers to better support healthcare providers and patients through their electronic health records (EHRs) and patient portals.
ghg and OptimizeRx will jointly market existing and newly developed products and services that are embedded in the doctor’s electronic workflow and provide physicians a suite of useful tools and information to support patient health. Powered by OptimizeRx’s SampleMD™ proprietary technology to automated delivery of product savings, support and information and with ghg’s premier strategic, creative and contract sales capabilities, these expanded services will provide instantaneous access to a range of information and on-demand services, including sampling, coupons, patient education, product information and (virtual) pharmaceutical rep support via the EHR.
The shifting healthcare environment has changed the way physicians work and how pharmaceutical companies support them. With a national shortage of physicians and mounting pressure to ensure positive health outcomes among patients, physicians have less and less time to see pharmaceutical representatives. More than half of physicians are not accessible to representatives, yet research shows that the top rated things physicians value from pharmaceutical/biotech companies are samples, coupons and patient education. As healthcare providers are increasingly relying on EHRs for information and workflow management, the opportunity to provide easy, on-demand tools that help physicians access valuable support is more critical than ever. The suite of expanded offerings by ghg and OptimizeRx will provide manufacturers and other healthcare companies a way to integrate their programs and offerings at point of context, directly and efficiently in physicians’ workflows.
“Today’s pay-for-performance environment puts pressure on physicians to deliver better health outcomes for patients. The more we can support the physician with impactful engagement tools the way they want them, the better they can help patients adhere to treatment plans and live healthier lives,” said Lynn O’Connor Vos, CEO of ghg. “The healthcare industry is a customer service business. And doctors are customers as well. These new tools will help pharma better support physicians with the information they need, when they need it, through the channel they access most. This will transform the physician-pharmaceutical relationship and positively impact people’s lives.”
OptimizeRx’s SampleMD™ proprietary technology is the leading platform to deliver patient savings and support within physician’s electronic workflow. Through its network of 350 EHRs reaching 250,000 healthcare providers, OptimizeRx delivers customized prescription vouchers, co-pay saving and other support programs tailored to the specific physician and patient type. Through this partnership, these platforms will be expanding new ways to further engage both the patient and physician, including a RepOnCall capability for physicians to access a live product rep, samples or schedule a future appointment. RepOnCall capabilities will be provided by OnCall, LLC, a ghg company and one of the most sophisticated contract sales organizations in the U.S.
“Our clients and platform partners are excited about further developing technologies to automate information the doctor has deemed valuable in treating their patients. ghg offers the ideal partnership to develop and deliver ‘better access to better healthcare’—which is our mission.” stated David Harrell, Chairman and Founder of OptimizeRx Corp.
About Grey Healthcare Group
ghg (grey healthcare group) is a global healthcare communications company capable of driving every aspect of healthcare communication. Headquartered in New York with offices in North America, Europe, and Asia, ghg works with leading companies to build world-class healthcare and pharmaceutical brands among medical professionals and consumers, with a unique storytelling approach that covers print, digital and television broadcast media, medical education, sales force presentations and managed access strategies. ghg is a member of the WPP Group, a global provider of advertising, branding, and marketing.
About OptimizeRx Corp.
OptimizeRx Corp. provides unique consumer and physician platforms to help patients better afford and comply with their medicines and healthcare products, while offering pharmaceutical and healthcare companies effective ways to expand patient awareness, access and adherence to their medications. For more information, please go to www.optimizerxcorp.com or www.samplemd.com .
This press release contains forward-looking statements within the definition of Section 27A of the Securities Act of 1933, as amended and such section 21E of the Securities Act of 1934, amended. These forward-looking statements should not be used to make an investment decision. The words 'estimate,' 'possible' and 'seeking' and similar expressions identify forward-looking statements, which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.